XBIT: XBiotech, Inc.
About
XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
Current Value
$6.661 Year Return
Current Value
$6.661 Year Return
Key Details
Market Cap
$201.80M
P/E Ratio
-6.17
1Y Stock Return
84.92%
1Y Revenue Growth
-100.00%
Dividend Yield
0.00%
Price to Book
1.1
Strategies that include XBIT
Stock's related to XBIT
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| GBIO | 27.24% | $88.17M | +14.78% | 0.00% |
| SEVN | 26.22% | $193.74M | +15.97% | 10.79% |
| SUNS | 26.06% | $103.02M | +31.64% | 1.41% |
| TX | 24.15% | $6.55B | -13.77% | 9.29% |
| SCSC | 23.62% | $1.19B | +56.59% | 0.00% |
| DCO | 23.30% | $962.87M | +31.30% | 0.00% |
| NNBR | 22.78% | $197.29M | +68.09% | 0.00% |
| PLXS | 22.66% | $4.35B | +52.96% | 0.00% |
| ONIT | 22.52% | $242.27M | +15.32% | 0.00% |
| BELFB | 22.35% | $944.56M | +39.39% | 0.36% |
| CRVL | 21.97% | $6.17B | +70.04% | 0.00% |
| RAPT | 21.96% | $36.71M | -92.31% | 0.00% |
| CSTE | 21.94% | $137.46M | +3.11% | 0.00% |
| EVCM | 21.69% | $2.14B | +31.79% | 0.00% |
| TLYS | 21.68% | $113.97M | -55.11% | 0.00% |
| PIPR | 21.65% | $6.05B | +124.17% | 0.54% |
| GSM | 21.45% | $849.24M | -8.50% | 0.87% |
| APPS | 21.26% | $152.48M | -70.95% | 0.00% |
| ITT | 21.22% | $12.67B | +42.89% | 0.80% |
| LVO | 20.65% | $79.50M | -18.53% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| AVB | <0.01% | $32.80B | +33.68% | 2.93% |
| TRUP | 0.01% | $2.23B | +99.73% | 0.00% |
| SNN | 0.01% | $10.92B | -2.49% | 2.97% |
| LAMR | -0.01% | $13.23B | +31.59% | 4.03% |
| ABEO | -0.03% | $251.70M | +39.52% | 0.00% |
| IART | 0.03% | $1.77B | -41.24% | 0.00% |
| SD | -0.03% | $437.26M | -9.14% | 3.74% |
| EE | 0.04% | $762.06M | +76.76% | 0.53% |
| AHCO | 0.05% | $1.33B | +16.35% | 0.00% |
| PODD | 0.06% | $18.38B | +40.63% | 0.00% |
| FYBR | 0.06% | $8.67B | +66.35% | 0.00% |
| AG | -0.06% | $1.94B | +18.38% | 0.28% |
| WRB | 0.06% | $23.68B | +34.33% | 0.68% |
| DPZ | 0.07% | $15.40B | +20.67% | 1.28% |
| PBR | 0.08% | $52.65B | -6.37% | 5.59% |
| RELY | 0.08% | $4.10B | -4.52% | 0.00% |
| ACIC | 0.09% | $642.09M | +62.64% | 0.00% |
| AXON | 0.10% | $48.14B | +178.25% | 0.00% |
| INFA | 0.10% | $8.08B | +7.83% | 0.00% |
| CRESY | 0.10% | $670.30M | +30.96% | 6.96% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MCK | -15.49% | $79.75B | +37.34% | 0.41% |
| CL | -14.47% | $77.00B | +21.96% | 2.09% |
| CHD | -13.49% | $27.50B | +19.29% | 1.01% |
| HLN | -13.41% | $43.23B | +14.51% | 1.63% |
| CAH | -12.91% | $29.87B | +16.57% | 1.63% |
| SMCI | -12.86% | $17.39B | +3.61% | 0.00% |
| RSG | -11.91% | $67.03B | +33.78% | 1.01% |
| CHWY | -11.81% | $14.63B | +75.40% | 0.00% |
| NKE | -11.45% | $111.79B | -30.41% | 1.94% |
| PG | -11.35% | $406.83B | +14.39% | 2.27% |
| APD | -11.30% | $73.11B | +19.91% | 2.14% |
| AGS | -11.25% | $476.80M | +57.01% | 0.00% |
| DVA | -10.55% | $13.46B | +65.00% | 0.00% |
| RYAN | -10.32% | $8.98B | +57.73% | 0.61% |
| BROS | -9.68% | $5.93B | +80.24% | 0.00% |
| PHG | -9.63% | $24.64B | +28.81% | 0.00% |
| IFF | -9.62% | $22.96B | +19.72% | 2.23% |
| FTNT | -9.27% | $72.06B | +77.50% | 0.00% |
| OHI | -9.13% | $10.84B | +26.39% | 6.62% |
| AEM | -9.05% | $41.91B | +68.56% | 1.90% |
ETF's related to XBIT
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| RSPA | 52.64% | $272.75M | 0% |
| QQA | 41.14% | $135.25M | 0% |
| EFAA | 33.86% | $116.17M | 0% |
| IJT | 25.47% | $6.67B | 0.18% |
| PAVE | 25.41% | $9.25B | 0.47% |
| SLYG | 25.19% | $3.72B | 0.15% |
| XSLV | 25.12% | $322.25M | 0.25% |
| XSMO | 24.84% | $1.32B | 0.39% |
| FXR | 24.81% | $2.09B | 0.61% |
| RDVI | 24.67% | $1.54B | 0.75% |
| XSVM | 24.51% | $843.94M | 0.37% |
| SDVY | 24.33% | $7.28B | 0.6% |
| RDVY | 24.12% | $13.03B | 0.49% |
| SLX | 24.03% | $88.97M | 0.56% |
| IWC | 24.01% | $943.89M | 0.6% |
| RYLD | 24.00% | $1.45B | 0.6% |
| SPGP | 24.00% | $4.22B | 0.36% |
| DFLV | 23.86% | $2.84B | 0.22% |
| KCE | 23.84% | $474.72M | 0.35% |
| PSC | 23.81% | $710.79M | 0.38% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| PCY | -<0.01% | $1.31B | 0.5% |
| GDXJ | -0.05% | $5.12B | 0.52% |
| CIBR | 0.07% | $7.08B | 0.59% |
| SOYB | -0.08% | $27.32M | 0.22% |
| EPU | 0.10% | $78.43M | 0.59% |
| PYLD | -0.11% | $2.27B | 0.55% |
| DIAL | -0.11% | $368.94M | 0.28% |
| LQDW | -0.13% | $207.27M | 0.34% |
| XLV | -0.14% | $38.54B | 0.09% |
| IVOL | -0.22% | $549.88M | 1.02% |
| TDTF | 0.24% | $720.34M | 0.18% |
| BUG | -0.24% | $786.41M | 0.5% |
| PWZ | -0.24% | $697.13M | 0.28% |
| ENZL | 0.28% | $85.02M | 0.5% |
| FUTY | -0.29% | $1.74B | 0.084% |
| BSCP | 0.35% | $4.04B | 0.1% |
| PREF | -0.36% | $1.01B | 0.55% |
| EMBD | -0.39% | $195.82M | 0.39% |
| HYMB | 0.40% | $2.81B | 0.35% |
| IZRL | 0.41% | $104.51M | 0.49% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -23.79% | $195.31M | 0.85% |
| TAIL | -21.79% | $68.06M | 0.59% |
| IBTE | -15.20% | $1.67B | 0.07% |
| SHV | -15.14% | $18.36B | 0.15% |
| IBDP | -14.95% | $2.05B | 0.1% |
| TBIL | -14.78% | $4.39B | 0.15% |
| BTAL | -14.64% | $379.51M | 1.43% |
| XONE | -14.08% | $550.61M | 0.03% |
| XHLF | -13.99% | $883.02M | 0.03% |
| ULST | -12.70% | $535.66M | 0.2% |
| FTSM | -12.48% | $6.07B | 0.45% |
| JUCY | -12.25% | $325.31M | 0.6% |
| UDN | -12.01% | $56.31M | 0.78% |
| GCOR | -11.68% | $393.62M | 0.14% |
| MTBA | -11.46% | $1.58B | 0.15% |
| FMB | -11.38% | $2.03B | 0.65% |
| ICSH | -11.12% | $5.55B | 0.08% |
| PULS | -11.11% | $8.81B | 0.15% |
| MUNI | -11.11% | $1.73B | 0.35% |
| KCCA | -10.97% | $219.64M | 0.87% |
News
Finnhub
AUSTIN, Texas — AUSTIN, Texas — XBiotech Inc. on Wednesday reported a loss of $5 million in its third quarter. On a per-share basis, the Austin, Texas-based company said it had a loss of 16...
Yahoo
AUSTIN, Texas (AP) — XBiotech Inc. XBIT) on Monday reported a loss of $13 million in its second quarter. The Austin, Texas-based company said it had a loss of 43 cents per share.
Yahoo
Findings Show Trends for Reduced Toxicities and Better Outcomes for Subjects Receiving ONIVYDE/5-FU Combination and Targeted anti-IL-1alpha TherapyAUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for advanced pancreatic cancer. Known as 1-BETTER, the study examined Natrunix (anti-interleukin-1alpha) antibody in combination with an established chemotherapy regimen
SeekingAlpha
XBiotech Inc.'s Hutrukin, Natrunix, and the True Human Antibody technology platform are advancing in medical studies. Click for my XBIT stock update.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.